New Age Alpha Advisors, LLC Halozyme Therapeutics, Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.47 Trillion
- Q4 2024
A detailed history of New Age Alpha Advisors, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 28,264 shares of HALO stock, worth $1.63 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
28,264Holding current value
$1.63 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
546Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$767 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$415 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$241 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$199 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.04B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...